PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
The Korean Journal of Urological Oncology10.22465/kjuo.2021.19.2.79202119279-91An Update of Gonadotropin-Releasing Hormone Antagonists in the Treatment of Advanced Prostate CancerJeong Hee Honghttp://kjuo.or.kr/upload/pdf/kjuo-19-2-79.pdf, http://kjuo.or.kr/journal/view.php?doi=10.22465/kjuo.2021.19.2.79, http://kjuo.or.kr/upload/pdf/kjuo-19-2-79.pdf
Therapeutic Advances in Urology10.1177/1756287211414457201133127-140An update on the use of gonadotropin-releasing hormone antagonists in prostate cancerLaurent Boccon-Gibod, Egbert van der Meulen, Bo-Eric Perssonhttp://journals.sagepub.com/doi/pdf/10.1177/1756287211414457, http://journals.sagepub.com/doi/pdf/10.1177/1756287211414457
The Prostate10.1002/pros.2990040604198346569-577Gonadotropin-releasing hormone agonistic analogues in the treatment of advanced prostatic carcinomaM. Koutsilieris, G. Tolishttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fpros.2990040604, https://onlinelibrary.wiley.com/doi/full/10.1002/pros.2990040604
Clinical Prostate Cancer10.1016/s1540-0352(11)70046-4200424209-211Abarelix (Plenaxis™): A Gonadotropin-Releasing Hormone Antagonist for Medical Castration in Patients with Advanced Prostate CancerG. Kesava Reddy, Vinay K. Jain, Oliver Sartorhttps://api.elsevier.com/content/article/PII:S1540035211700464?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1540035211700464?httpAccept=text/plain
International Journal of Urology10.1111/j.1442-2042.2012.02997.x2012197594-601Gonadotropin-releasing hormone: An update review of the antagonists versus agonistsHein Van Poppel, Laurence Klotzhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1442-2042.2012.02997.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1442-2042.2012.02997.x/fullpdf
European Urology10.1016/j.eururo.2008.04.1012008544726-727Management of Advanced Prostate Cancer: Gonadotropin-Releasing Hormone Blockers Might Improve PrognosisAxel Heidenreichhttps://api.elsevier.com/content/article/PII:S0302283808005721?httpAccept=text/plain, https://api.elsevier.com/content/article/PII:S0302283808005721?httpAccept=text/xml
Cancer10.1002/1097-0142(19931201)72:11<3263::aid-cncr2820721122>3.0.co;2-v199372113263-3270Antagonists of bombesin/gastrin-releasing peptide as adjuncts to agonists of luteinizing hormone–releasing hormone in the treatment of experimental prostate cancerJacek Pinski, Gabor Halmos, Karoly Szepeshazi, Andrew V. Schallyhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19931201)72:11%3C3263::AID-CNCR2820721122%3E3.0.CO;2-V, https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19931201)72:11%3C3263::AID-CNCR2820721122%3E3.0.CO;2-V
Cancer Treatment Reviews10.1016/j.ctrv.2012.12.0032013396647-663Gonadotropin-releasing hormone receptors as molecular therapeutic targets in prostate cancer: Current options and emerging strategiesPatrizia Limonta, Marilena Maneahttps://api.elsevier.com/content/article/PII:S0305737212002423?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0305737212002423?httpAccept=text/plain
International Journal of Urology10.1111/iju.142142020274356-356Editorial Comment to Treatment‐induced changes in levels of brain natriuretic peptide in prostate cancer patients receiving gonadotropin‐releasing hormone antagonists or agonistsSayuri Takahashihttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fiju.14214, https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14214, https://onlinelibrary.wiley.com/doi/full-xml/10.1111/iju.14214, https://onlinelibrary.wiley.com/doi/pdf/10.1111/iju.14214
Urology10.1016/s0090-4295(01)01238-9200158224-27Luteinizing hormone–releasing hormone antagonists in prostate cancerHans J Strickerhttps://api.elsevier.com/content/article/PII:S0090429501012389?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0090429501012389?httpAccept=text/plain